MDPile
SpecialtyNews
RSS icon
MDPile

  • New Light Therapy for Early-Stage CTCL Shows Promising Results

    New Light Therapy for Early-Stage CTCL Shows Promising Results

    7/9/2024

  • Promising Results for HyBryte™ in Treating Early-Stage CTCL

    Promising Results for HyBryte™ in Treating Early-Stage CTCL

    7/9/2024

  • New Hope for Hair Loss: Eirion's Revolutionary Treatment Enters Clinical Trial

    New Hope for Hair Loss: Eirion's Revolutionary Treatment Enters Clinical Trial

    7/1/2024

  • New Hope for Eczema: Innovative Live Biotherapeutic Treatment by Concerto Biosciences

    New Hope for Eczema: Innovative Live Biotherapeutic Treatment by Concerto Biosciences

    6/26/2024

  • Breakthrough Treatment for Eczema: New Biotherapeutic Product Shows Promise

    Breakthrough Treatment for Eczema: New Biotherapeutic Product Shows Promise

    6/26/2024

  • HyBryte™ Shows Promising Results Over Valchlor® in Skin Cancer Treatment

    HyBryte™ Shows Promising Results Over Valchlor® in Skin Cancer Treatment

    6/25/2024

  • Biofrontera Launches Advanced Red Light Therapy for Skin Conditions

    Biofrontera Launches Advanced Red Light Therapy for Skin Conditions

    6/24/2024

  • New FDA-Approved Adbry® Autoinjector Simplifies Atopic Dermatitis Treatment for Adults

    New FDA-Approved Adbry® Autoinjector Simplifies Atopic Dermatitis Treatment for Adults

    6/13/2024

  • Promising Treatment for Atopic Dermatitis Shows Impressive Results

    Promising Treatment for Atopic Dermatitis Shows Impressive Results

    6/11/2024

  • Innovative Fractional Laser for Hair Loss

    Innovative Fractional Laser for Hair Loss

    6/5/2024

  • Revolutionizing Skin Cancer Detection with AI-Enhanced Imaging: Enspectra Health Takes the Lead

    Revolutionizing Skin Cancer Detection with AI-Enhanced Imaging: Enspectra Health Takes the Lead

    6/5/2024

  • New ProteXidine Molecule: A Breakthrough in UV Protection

    New ProteXidine Molecule: A Breakthrough in UV Protection

    6/5/2024

  • Breakthrough: Long-Term Efficacy and Safety of Stapokibart for Severe Eczema

    Breakthrough: Long-Term Efficacy and Safety of Stapokibart for Severe Eczema

    6/4/2024

  • Breakthrough for Severe Eczema: New Long-term Findings on Stapokibart

    Breakthrough for Severe Eczema: New Long-term Findings on Stapokibart

    6/3/2024

  • New Long-Term Data Shows Promising Results for Stapokibart in Treating Severe Atopic Dermatitis

    New Long-Term Data Shows Promising Results for Stapokibart in Treating Severe Atopic Dermatitis

    6/3/2024

  • New Insights and Treatments for Seborrheic Dermatitis: Beyond Yeast

    New Insights and Treatments for Seborrheic Dermatitis: Beyond Yeast

    5/29/2024

  • New Cream Revolutionizes Treatment for Severe Eczema: Promising Results and High Tolerance

    New Cream Revolutionizes Treatment for Severe Eczema: Promising Results and High Tolerance

    5/28/2024

  • New Psoriasis Treatment Shows Promising Results in Clinical Trials

    New Psoriasis Treatment Shows Promising Results in Clinical Trials

    5/28/2024

  • Antihypertensive Drugs Linked to Increased Risk of Eczematous Dermatitis in Elderly

    Antihypertensive Drugs Linked to Increased Risk of Eczematous Dermatitis in Elderly

    5/26/2024

  • Breakthrough Treatment for Hidradenitis Suppurativa: Phase 3 Trials Show Promising Results

    Breakthrough Treatment for Hidradenitis Suppurativa: Phase 3 Trials Show Promising Results

    5/23/2024

  • Understanding JAK Inhibitors: Safety Measures for Alopecia Treatment

    Understanding JAK Inhibitors: Safety Measures for Alopecia Treatment

    5/21/2024

  • When and Where: Key Factors for Biopsies in Early-Stage Melanomas

    When and Where: Key Factors for Biopsies in Early-Stage Melanomas

    5/21/2024

  • Isotretinoin and Severe Acne: Balancing Treatment Benefits and Risks

    Isotretinoin and Severe Acne: Balancing Treatment Benefits and Risks

    5/20/2024

  • Secukinumab Trial Results in Lichen Planus: What You Need to Know

    Secukinumab Trial Results in Lichen Planus: What You Need to Know

    5/20/2024

  • Johnson & Johnson's New Move in Dermatology: Acquisition of Proteologix

    Johnson & Johnson's New Move in Dermatology: Acquisition of Proteologix

    5/19/2024

  • Breakthrough Study: New Hope for Children with Alopecia Areata

    Breakthrough Study: New Hope for Children with Alopecia Areata

    5/18/2024

  • Exploring the Health Risks and Safety Concerns of Modern Tattoos

    Exploring the Health Risks and Safety Concerns of Modern Tattoos

    5/17/2024

  • Tildrakizumab Shows Promise for Psoriasis Unresponsive to Anti-IL17 Treatments

    Tildrakizumab Shows Promise for Psoriasis Unresponsive to Anti-IL17 Treatments

    5/14/2024

  • New Treatment Shines in Battling Psoriasis and Nail Inflammation

    New Treatment Shines in Battling Psoriasis and Nail Inflammation

    5/14/2024

  • Setback in Advanced Melanoma Treatment: Coformulation Trial Halted

    Setback in Advanced Melanoma Treatment: Coformulation Trial Halted

    5/13/2024

  • Revolutionizing Acne Treatment: The New Triple-Threat Gel Shows Promising Results

    Revolutionizing Acne Treatment: The New Triple-Threat Gel Shows Promising Results

    5/13/2024

  • Breakthrough Gel Proves Effective for Moderate-to-Severe Acne Treatment

    Breakthrough Gel Proves Effective for Moderate-to-Severe Acne Treatment

    5/13/2024

  • Danger in Disguise: Rising Incidents of Counterfeit Botox in the US

    Danger in Disguise: Rising Incidents of Counterfeit Botox in the US

    5/13/2024

  • Enhancing Facial Anti-Aging Treatments: A New Skincare Guide for Energy-Based Procedures

    Enhancing Facial Anti-Aging Treatments: A New Skincare Guide for Energy-Based Procedures

    5/13/2024

  • Innovative Telemedicine Approaches for Managing Nail Psoriasis with Behavioral Complications

    Innovative Telemedicine Approaches for Managing Nail Psoriasis with Behavioral Complications

    5/11/2024

...
0
Terms & Conditions
Privacy Policy
MDPile